Role of MicroRNA-29c in the Chemoprevention of Gastric Cancer By a Selective COX-2 Inhibitor

被引:0
|
作者
Saito, Yoshimasa
Suzuki, Hidekazu
Nakagawa, Izumi
Matsuzaki, Juntaro
Iwasaki, Eisuke
Tsugawa, Hitoshi
Imaeda, Hiroyiki
Hibi, Toshifumi
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A167 / A168
页数:2
相关论文
共 50 条
  • [21] Regulated cyclooxygenase-2 (Cox-2) expression to investigate the role of Cox-2 in gastric cancer
    Griffin, NM
    Cox, CM
    Scully, GM
    Doherty, GA
    Fitzgerald, DJ
    GASTROENTEROLOGY, 2004, 126 (04) : A49 - A49
  • [22] Selective COX-2 inhibitor induces gastric damage in adrenalectomized rats.
    Ohno, R
    Filaretova, L
    Tanaka, A
    Yokota, A
    Takeuchi, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 101P - 101P
  • [23] COX-2 and colon cancer: Potential targets for chemoprevention
    Fournier, DB
    Gordon, GB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, : 97 - 102
  • [24] Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor
    Eibl, G
    Takata, Y
    Boros, LG
    Liu, J
    Okada, Y
    Reber, HA
    Hines, OJ
    CANCER RESEARCH, 2005, 65 (03) : 982 - 990
  • [25] Clinical pharmacology of the selective COX-2 inhibitor
    Burian, M
    Geisslinger, G
    ORTHOPADE, 2003, 32 (12): : 1078 - +
  • [26] Etoricoxib: A highly selective COX-2 inhibitor
    Martina, SD
    Vesta, KS
    Ripley, TL
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (05) : 854 - 862
  • [28] Etodolac: An overview of a selective COX-2 inhibitor
    Jones R.A.
    InflammoPharmacology, 1999, 7 (3) : 269 - 275
  • [29] NSAIDs: gastroprotection or selective COX-2 inhibitor?
    Dickman, A
    Ellershaw, J
    PALLIATIVE MEDICINE, 2004, 18 (04) : 275 - 286
  • [30] The role of the cyclooxygenase-2 (COX-2) expression in gastric cancer
    Joo, YE
    Oh, WT
    Rew, JS
    Choi, SK
    Kim, SJ
    Park, CS
    GASTROENTEROLOGY, 2002, 122 (04) : A599 - A599